simvastatin has been researched along with Infection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Granger, DN; Jin, R; Li, G; Liu, L; Nanda, A; Zhu, X | 1 |
Finsterer, J; Zuntner, G | 1 |
Alvarez-Sabín, J; Chacón, P; Hereu, P; Krupinski, J; Millán, M; Molina, CA; Montaner, J; Quintana, M; Rubio, F | 1 |
1 trial(s) available for simvastatin and Infection
Article | Year |
---|---|
Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infections; Inflammation Mediators; Male; Middle Aged; Pilot Projects; Simvastatin; Stroke; Treatment Outcome | 2008 |
2 other study(ies) available for simvastatin and Infection
Article | Year |
---|---|
Simvastatin attenuates stroke-induced splenic atrophy and lung susceptibility to spontaneous bacterial infection in mice.
Topics: Animals; Anticholesteremic Agents; Apoptosis; Atrophy; Bacterial Infections; bcl-2-Associated X Protein; Brain Infarction; Disease Models, Animal; Humans; Infarction, Middle Cerebral Artery; Infections; Interferon-gamma; Lung; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-bcl-2; Simvastatin; Spleen; Splenectomy; Stroke | 2013 |
Rhabdomyolysis from Simvastatin triggered by infection and muscle exertion.
Topics: Adult; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Infections; Physical Exertion; Precipitating Factors; Rhabdomyolysis; Simvastatin | 2005 |